Impacts of tongnao huoluo acupuncture therapy on BI and NIHSS of patients with acute cerebral infarction.
- Author:
Ji-ying LI
1
;
Yang ZHAO
;
Zhen-nian ZHANG
Author Information
- Publication Type:Journal Article
- MeSH: Acupuncture Therapy; methods; Adult; Aged; Cerebral Infarction; therapy; Female; Humans; Male; Middle Aged; Treatment Outcome
- From: Chinese Journal of Integrated Traditional and Western Medicine 2011;31(1):28-32
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo evaluate the effect of Tongnao Huoluo Acupuncture (THA) therapy on acute cerebral infarction (ACI).
METHODSAdopting multi-centered, randomized and controlled method, 397 ACI patients from 10 hospitals subjected to the study were treated according to the initiating time (IT) of disease during hospitalization: the 138 patients of stage-1 with IT < or =6 h, were randomly assigned to three groups, treated respectively with THA (Group A), thrombolysis with urokinase (Group B) and Batroxobin (Group C); the 140 patients of stage-2 with IT within 6-48 h, and 119 patients of stage-3 with IT within 48 h-14 d were randomly assigned to three groups, treated respectively with THA (Group D) body acupuncture (Group E), and conventional treatment (Group F). Therapeutic effect was evaluated by NIHSS scores estimated at the day 1, 3, 7, 14, 28 and 90 of treatment, and the Barthel Index (BI) measured at day 14, 28 and 90.
RESULTSEffect in Group A was insignificantly different from that in Group B (P > 0.05), but was different from that in Group C significantly (P < 0.01). At day 90, the percentage of patients with high BI (HBI%, patients with BI >95%) was insignificantly different in Group A vs. B (P > 0.05), but was significantly different in Group A vs. C (P < 0.01). Comparisons between Group D, E and F showed that the therapeutic effect in Group D was equivalent to that in Group E (P < 0.05), but better than that in Group F (P < 0.01), and HBI% in Group D was superior than that in the other two groups (P < 0.01).
CONCLUSIONSTHA therapy shows favorable effects in reducing the crippling rate and improving the living capacity of ACI patients.